People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.
Molecular glue could pave the way for new generation of drugs
A breakthrough class of molecular glue identified at the University of Dundee could pave the way for a new generation of drugs to target cancers